1. Home
  2. NMAI vs QTRX Comparison

NMAI vs QTRX Comparison

Compare NMAI & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen Multi-Asset Income Fund of Beneficial Interest

NMAI

Nuveen Multi-Asset Income Fund of Beneficial Interest

HOLD

Current Price

$13.88

Market Cap

455.9M

Sector

Finance

ML Signal

HOLD

Logo Quanterix Corporation

QTRX

Quanterix Corporation

HOLD

Current Price

$2.66

Market Cap

160.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NMAI
QTRX
Founded
2021
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Laboratory Analytical Instruments
Sector
Finance
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
455.9M
160.0M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NMAI
QTRX
Price
$13.88
$2.66
Analyst Decision
Hold
Analyst Count
0
2
Target Price
N/A
$6.00
AVG Volume (30 Days)
97.0K
1.4M
Earning Date
01-01-0001
05-06-2026
Dividend Yield
13.14%
N/A
EPS Growth
N/A
N/A
EPS
0.64
N/A
Revenue
N/A
$37,632,000.00
Revenue This Year
N/A
$25.49
Revenue Next Year
N/A
$10.04
P/E Ratio
$21.58
N/A
Revenue Growth
N/A
64.52
52 Week Low
$11.99
$2.40
52 Week High
$14.38
$8.77

Technical Indicators

Market Signals
Indicator
NMAI
QTRX
Relative Strength Index (RSI) 54.59 36.62
Support Level $12.64 N/A
Resistance Level $14.38 $3.74
Average True Range (ATR) 0.21 0.29
MACD -0.05 -0.00
Stochastic Oscillator 33.53 23.01

Price Performance

Historical Comparison
NMAI
QTRX

About NMAI Nuveen Multi-Asset Income Fund of Beneficial Interest

Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund's investment objective is to provide total return through high current income and capital appreciation.

About QTRX Quanterix Corporation

Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.

Share on Social Networks: